1-20 of 57
Authors: Maria Castro
Journal Article
CNSC-18. A SCOPING REVIEW OF HISTONE 3.3 G34R/V HIGH-GRADE GLIOMA: EPIGENETIC AND MOLECULAR PROFILES, CLINICOPATHOLOGY, AND TREATMENT AVENUES Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii44, https://doi.org/10.1093/neuonc/noae165.0174
Published: 11 November 2024
Journal Article
TMIC-79. IDH1-R132H REWIRES AUTOPHAGY IN THE GLIOMA MICROENVIRONMENT TO FACILITATE TUMOR PROGRESSION AND RESPONSE TO RADIATION Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii316, https://doi.org/10.1093/neuonc/noae165.1256
Published: 11 November 2024
Journal Article
EXTH-11. PEDIATRIC GLIOMA IMMUNE PROFILING IDENTIFIES TIM3 AS A THERAPEUTIC TARGET IN BRAF-FUSION PILOCYTIC ASTROCYTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii238, https://doi.org/10.1093/neuonc/noae165.0942
Published: 11 November 2024
Journal Article
TMIC-62. INVESTIGATING THE ROLE OF OSTEOPONTIN IN RADIORESISTANCE OF H3.3-G34R PEDIATRIC HIGH-GRADE GLIOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii312, https://doi.org/10.1093/neuonc/noae165.1240
Published: 11 November 2024
Journal Article
TMIC-06. TUMOR ASSOCIATED MACROPHAGES DRIVE TUMOR PROGRESSION AND ARE TRANSCRIPTIONALLY SHAPED BY HISTONE MUTATIONS IN DIFFUSE MIDLINE GLIOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii298, https://doi.org/10.1093/neuonc/noae165.1184
Published: 11 November 2024
Journal Article
TMIC-70. A TRANSCRIPTIONALLY ACTIVE EPIGENETIC IMPRINTING OF THE JAK/STAT PATHWAY MEDIATED BY H3.3-G34 MUTATIONS IN PEDIATRIC HIGH-GRADE GLIOMA (PHGG) INDUCES AN IMMUNOREACTIVE TME Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v294, https://doi.org/10.1093/neuonc/noad179.1136
Published: 10 November 2023
Journal Article
EPCO-30. UNCOVERING MECHANISMS OF RESISTANCE IN PEDIATRIC HIGH-GRADE GLIOMA (PHGG) Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v130, https://doi.org/10.1093/neuonc/noad179.0493
Published: 10 November 2023
Journal Article
IMMU-15. INTERPLAY BETWEEN ATRXAND IDH1 MUTATIONS GOVERNS INNATE IMMUNE RESPONSES IN DIFFUSE GLIOMAS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v144, https://doi.org/10.1093/neuonc/noad179.0547
Published: 10 November 2023
Journal Article
IMMU-19. MUTANT ISOCITRATE DEHYDROGENASE 1 IN GLIOMA CAUSES A REDUCTION IN ADENOSINERGIC PATHWAY SIGNALING WITHIN THE TUMOR MICROENVIRONMENT Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v145, https://doi.org/10.1093/neuonc/noad179.0551
Published: 10 November 2023
Journal Article
TMIC-03. TARGETING THE COLLAGEN RECEPTOR DDR1 PROMOTES ANTI-GLIOMA IMMUNITY BY REMODELING COLLAGEN FIBER ARCHITECTURE Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v278, https://doi.org/10.1093/neuonc/noad179.1069
Published: 10 November 2023
Journal Article
PATH-60. BRAIN TUMORS: FROM ONCOSTREAMS TO LIQUID CRYSTALS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v182, https://doi.org/10.1093/neuonc/noad179.0689
Published: 10 November 2023
Journal Article
CTIM-28. FIRST-IN-HUMAN TRANSGENE DETECTION 17 MONTHS POST-ADENOVIRAL THERAPY Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v68, https://doi.org/10.1093/neuonc/noad179.0268
Published: 10 November 2023
Journal Article
TMIC-16. THE COLLAGEN RECEPTOR LAIR-1 ALTERS THE GLIOMA MICROENVIRONMENT AND REGULATES TUMOR AGGRESSIVE BEHAVIOR Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v281, https://doi.org/10.1093/neuonc/noad179.1082
Published: 10 November 2023
Journal Article
TMIC-28. TARGETING TUMOR-ASSOCIATED SMOOTH MUSCLE ACTIN (ACTA2) EXPRESSION IN MOUSE PRE-CLINICAL GLIOMA MODELS REDUCES TUMOR PROGRESSION AND EXTENDS SURVIVAL Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v284, https://doi.org/10.1093/neuonc/noad179.1094
Published: 10 November 2023
Journal Article
NIMG-30. AI-BASED MOLECULAR CLASSIFICATION OF DIFFUSE GLIOMAS USING RAPID, LABEL-FREE OPTICAL HISTOLOGY Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii169, https://doi.org/10.1093/neuonc/noac209.648
Published: 14 November 2022
Journal Article
CSIG-09. THERAPEUTIC TARGETING OF PRENATAL PONTINE ID1 SIGNALING IN DIFFUSE MIDLINE GLIOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii40, https://doi.org/10.1093/neuonc/noac209.158
Published: 14 November 2022
Journal Article
CNSC-14. ROLE OF A COLLAGEN RECEPTOR, LAIR-1, IN GLIOMA CELLS: A POTENTIAL THERAPEUTIC TARGET Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii24–vii25, https://doi.org/10.1093/neuonc/noac209.095
Published: 14 November 2022
Journal Article
TMIC-18. ROLE OF DISCOIDIN DOMAIN RECEPTORS (DDR1/DDR2) IN SENSITIZATION OF GLIOMAS TOWARDS RADIOTHERAPY Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii275, https://doi.org/10.1093/neuonc/noac209.1062
Published: 14 November 2022
Journal Article
TMIC-62. INHIBITION OF TUMOR-ASSOCIATED COL1A1 MATRIX ARRESTS GLIOMA MESENCHYMAL TRANSFORMATION AND REPROGRAMS THE TUMOR MICROENVIRONMENT Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii285, https://doi.org/10.1093/neuonc/noac209.1106
Published: 14 November 2022
Journal Article
IMMU-12. Exploring and modulating the tumour immune microenvironment to facilitate the selection of immunotherapies for paediatric-type diffuse high-grade glioma Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i83–i84, https://doi.org/10.1093/neuonc/noac079.305
Published: 03 June 2022
